143 related articles for article (PubMed ID: 15379942)
61. Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors.
Carver BS; Serio AM; Bajorin D; Motzer RJ; Stasi J; Bosl GJ; Vickers AJ; Sheinfeld J
J Clin Oncol; 2007 Dec; 25(35):5603-8. PubMed ID: 17998544
[TBL] [Abstract][Full Text] [Related]
62. Germ cell tumors: an update of recent data and review of active protocols in stage I and metastatic disease.
Hahn NM; Sweeney CJ
Urol Oncol; 2005; 23(4):293-302. PubMed ID: 16018947
[TBL] [Abstract][Full Text] [Related]
63. Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis.
von Schlippe M; Fowler CJ; Harland SJ
Br J Cancer; 2001 Sep; 85(6):823-6. PubMed ID: 11556831
[TBL] [Abstract][Full Text] [Related]
64. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
Ondrus D; Ondrusova M; Hornak M; Matoska J
Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
[TBL] [Abstract][Full Text] [Related]
65. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
[TBL] [Abstract][Full Text] [Related]
66. Treatment results of 59 young patients with nasopharyngeal carcinoma.
Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
[TBL] [Abstract][Full Text] [Related]
67. Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients.
Guntinas-Lichius O; Kreppel MP; Stuetzer H; Semrau R; Eckel HE; Mueller RP
Eur J Surg Oncol; 2007 Mar; 33(2):222-8. PubMed ID: 17127030
[TBL] [Abstract][Full Text] [Related]
68. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Divrik RT; Akdoğan B; Ozen H; Zorlu F
J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
[TBL] [Abstract][Full Text] [Related]
69. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
Rose PG; Ali S; Watkins E; Thigpen JT; Deppe G; Clarke-Pearson DL; Insalaco S;
J Clin Oncol; 2007 Jul; 25(19):2804-10. PubMed ID: 17502627
[TBL] [Abstract][Full Text] [Related]
70. Ovarian cancer: an analysis of forty-four patients at the National Radiotherapy Centre, Accra--Ghana.
Vanderpuye V; Yarney J
West Afr J Med; 2007; 26(2):93-6. PubMed ID: 17939307
[TBL] [Abstract][Full Text] [Related]
71. Relationship between platinum-DNA adducts in leukocytes of patients with advanced germ cell cancer and survival.
Fisch MJ; Howard KL; Einhorn LH; Sledge GW
Clin Cancer Res; 1996 Jun; 2(6):1063-6. PubMed ID: 9816268
[TBL] [Abstract][Full Text] [Related]
72. Clinical use of serum TRA-1-60 as tumor marker in patients with germ cell cancer.
Lajer H; Daugaard G; Andersson AM; Skakkebaek NE
Int J Cancer; 2002 Jul; 100(2):244-6. PubMed ID: 12115576
[TBL] [Abstract][Full Text] [Related]
73. Fertility after testicular cancer treatments: results of a large multicenter study.
Huyghe E; Matsuda T; Daudin M; Chevreau C; Bachaud JM; Plante P; Bujan L; Thonneau P
Cancer; 2004 Feb; 100(4):732-7. PubMed ID: 14770428
[TBL] [Abstract][Full Text] [Related]
74. Chemotherapy for metastatic testicular cancer: The first nationwide multi-institutional study by the Cancer Registration Committee of the Japanese Urological Association.
Shiraishi T; Nakamura T; Ukimura O;
Int J Urol; 2018 Aug; 25(8):730-736. PubMed ID: 30016829
[TBL] [Abstract][Full Text] [Related]
75. Ukrain treatment in a patient with non-seminomatous germ-cell tumour of testis (case report).
Sakalo VS; Korsh OB; Melnyk A
Drugs Exp Clin Res; 1996; 22(3-5):263-5. PubMed ID: 8899344
[TBL] [Abstract][Full Text] [Related]
76. [Failure of therapy in non-seminomatous tumor of the testes].
Lalowicz I
Pol Tyg Lek; 1993 Jun 21-28; 48(25-26):557-9. PubMed ID: 8008649
[TBL] [Abstract][Full Text] [Related]
77. Outcome of patients with HIV-related germ cell tumours: a case-control study.
Powles T; Bower M; Shamash J; Stebbing J; Ong J; Daugaard G; De Ruiter A; Johnson M; Fisher M; Anderson J; Nelson M; Gazzard B; Oliver T
Br J Cancer; 2004 Apr; 90(8):1526-30. PubMed ID: 15083180
[TBL] [Abstract][Full Text] [Related]
78. [Long-term side effects of chemotherapy for testicular cancer].
Kawai K
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1300-5. PubMed ID: 12146015
[TBL] [Abstract][Full Text] [Related]
79. Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy; cardiovascular risk factors and signs of vascular damage.
de Vos FY; Nuver J; Willemse PH; van der Zee AG; Messerschmidt J; Burgerhof JG; de Vries EG; Gietema JA
Eur J Cancer; 2004 Mar; 40(5):696-700. PubMed ID: 15010070
[TBL] [Abstract][Full Text] [Related]
80. Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines.
Dunn TA; Schmoll HJ; Grünwald V; Bokemeyer C; Casper J
Invest New Drugs; 1997; 15(2):109-14. PubMed ID: 9220289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
